SUMER JACQUELYN L
SEC insider (Form 3/4/5 filer). CIK 0001844824. Chief Legal Officer at Cullinan Therapeutics, Inc. (CGEM). 8 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in CAMBRIDGE, MA.
Companies SUMER JACQUELYN L has filed insider reports for
- Cullinan Therapeutics, Inc. (CGEM): Officer, Chief Legal Officer
SUMER JACQUELYN L
CIK: 0001844824
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Cullinan Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (8 total)
- Jun 30, 2026CGEM
Cullinan Therapeutics, Inc.
AwardDirect2.5K shares at avg. $8.60$21K - Feb 24, 2026CGEM
Cullinan Therapeutics, Inc.
SaleDirect3.6K shares at avg. $14.47$52K - Feb 20, 2026CGEM
Cullinan Therapeutics, Inc.
SaleDirect3.7K shares at avg. $13.62$51K - Feb 18, 2026CGEM
Cullinan Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
230K shares- - Dec 18, 2025CGEM
Cullinan Therapeutics, Inc.
SaleDirect3.5K shares at avg. $9.67$34K - Feb 25, 2025CGEM
Cullinan Therapeutics, Inc.
SaleDirect3.8K shares at avg. $8.53$32K - Feb 19, 2025CGEM
Cullinan Therapeutics, Inc.
AwardDirect50K shares- - Dec 18, 2024CGEM
Cullinan Therapeutics, Inc.
SaleDirect3.5K shares at avg. $11.41$40K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 30, 2026 | CGEM Cullinan Therapeutics, Inc. | Award | 2,470 | $8.60 | $21,242 | Direct |
| Feb 24, 2026 | CGEM Cullinan Therapeutics, Inc. | Sale | 3,601 | $14.47 | $52,106 | Direct |
| Feb 20, 2026 | CGEM Cullinan Therapeutics, Inc. | Sale | 3,742 | $13.62 | $50,966 | Direct |
| Feb 18, 2026 | CGEM Cullinan Therapeutics, Inc. | Award Stock Option (Right to Buy) | 230,000 | - | - | Direct |
| Dec 18, 2025 | CGEM Cullinan Therapeutics, Inc. | Sale | 3,480 | $9.67 | $33,652 | Direct |
| Feb 25, 2025 | CGEM Cullinan Therapeutics, Inc. | Sale | 3,756 | $8.53 | $32,039 | Direct |
| Feb 19, 2025 | CGEM Cullinan Therapeutics, Inc. | Award | 50,000 | - | - | Direct |
| Dec 18, 2024 | CGEM Cullinan Therapeutics, Inc. | Sale | 3,482 | $11.41 | $39,730 | Direct |
1-8 of 8 transactions